Emily Peterson Alva, Director at Amneal Pharmaceuticals, Inc. (AMRX), sold 80,000 shares at $8.90 ($712K) on 2025-03-05, disclosed to the SEC on 2025-03-07.
Open-market sale of $712k AMRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.